Patents by Inventor Dominique Pons

Dominique Pons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazole derivatives, preparation and user thereof as medicine
    Patent number: 8188133
    Abstract: The invention concerns novel imidazole derivatives of general formula (I), wherein Z? and Z represent different variable groups. Said products have an antitumoral activity. The invention also concerns pharmaceutical compositions containing said products and their use for preparing antitumoral medicine.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: May 29, 2012
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Anne-Marie Liberatore, Dennis Bigg, Dominique Pons, Grégoire Prevost
  • TRIAMINOPYRIMIDINE CYCLOBUTENEDIONE DERIVATIVES USED AS PHOSPHATASE CDC25 INHIBITORS
    Publication number: 20100173910
    Abstract: The present invention relates to triaminopyrimidine derivatives of formula (I) where Y, R3, W, R4a, R5a, R4b, R5b, n and m are variable. These compounds have CDC25 phosphatase-inhibiting activity and can therefore be used as drugs in diseases in which CDC25 phosphatases are involved. The invention also relates to pharmaceutical compositions containing said products and methods of using the drug.
    Type: Application
    Filed: July 10, 2008
    Publication date: July 8, 2010
    Applicant: IPDRN PHSTMS D.S.S.
    Inventors: Anne-Marie Liberatore, Dominique Pons, Dennis Bigg, Grégorie Prevost, Marie-Christine Brezak Pannetier
  • TRIAMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF CDC25 PHOSPHATASE
    Publication number: 20100137275
    Abstract: The present invention relates to the novel triaminopyrimidine derivatives of formula (I) in which R1, R2, W, R3, R4, and R5 are variable groups. These products have a Cdc25-phosphatase-inhibiting activity. The invention also relates to a process for synthesizing these compounds and also to therapeutic compositions containing these products and to the use thereof as medicaments.
    Type: Application
    Filed: April 30, 2008
    Publication date: June 3, 2010
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Grégorie Prevost, Anne-Marie Liberatore, Dennis Bigg, Dominique Pons
  • Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    Patent number: 7576241
    Abstract: A compound of the formula wherein the substituents are defined as in the specification useful as intermediates.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: August 18, 2009
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Serge Auvin, Pierre-Etienne Chabrier de Lassauniere, Jeremiah Harnett, Dominique Pons, Gerard Ulibarri
  • NOVEL IMIDAZOLE DERIVATIVES, PREPARATION AND USER THEREOF AS MEDICINE
    Publication number: 20090186930
    Abstract: The invention concerns novel imidazole derivatives of general formula (I), wherein Z? and Z represent different variable groups. Said products have an antitumoral activity. The invention also concerns pharmaceutical compositions containing said products and their use for preparing antitumoral medicine.
    Type: Application
    Filed: April 26, 2007
    Publication date: July 23, 2009
    Applicant: Societe de Conseils de Recherches et D' Applications Scientifiques (S.C.R.A.S.)
    Inventors: Anne-Marie Liberatore, Dennis Bigg, Dominique Pons, Grégoire Prevost
  • Imidazole derivatives, their preparation and their use as medicaments
    Patent number: 7534805
    Abstract: Novel imidazole compounds of the formula wherein the substituents are as defined in the application having antitumoral activity and use thereof.
    Type: Grant
    Filed: May 26, 2004
    Date of Patent: May 19, 2009
    Assignee: Societe de Conseils de Recherches Et d'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Dennis Bigg, Anne-Marie Liberatore, Dominique Pons
  • Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    Patent number: 7473779
    Abstract: Novel derivatives of amidines of formula wherein the substituents are defined as in the specification which are useful for inhibiting activity on NO-synthase enzymes producing nitrogen mono oxide and/or trapping the reactive oxygen species (ROS) making them useful for treating various diseases.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: January 6, 2009
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Serge Auvin, Pierre-Etienne Chabrier de Lassauniere, Jeremiah Harnett, Dominique Pons, Gérard Ulibarri
  • Novel imidazole derivatives, their preparation and their use as medicaments
    Publication number: 20070066542
    Abstract: Novel imidazole compounds of the formula wherein the substituents are as defined in the application having antitumoral activity and use thereof.
    Type: Application
    Filed: May 26, 2004
    Publication date: March 22, 2007
    Applicant: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.)
    Inventors: Dennis Bigg, Anne-Marie Liberatore, Dominique Pons
  • New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    Publication number: 20060084667
    Abstract: Compounds of the formula wherein the substituents are as defined in the specification useful as intermediates.
    Type: Application
    Filed: October 14, 2005
    Publication date: April 20, 2006
    Inventors: Serge Auvin, Pierre-Etienne Chabrier de Lassauniere, Jeremiah Harnett, Dominique Pons, Gerard Ulibarri
  • New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    Publication number: 20050261269
    Abstract: Novel derivatives of amidines of formula wherein the substituents are defined as in the specification which are useful for inhibiting activity on NO-synthase enzymes producing nitrogen mono oxide and/or trapping the reactive oxygen species (ROS) making them useful for treating various diseases.
    Type: Application
    Filed: September 12, 2003
    Publication date: November 24, 2005
    Inventors: Serge Auvin, Pierre-Etienne Chabrier de Lassauniere, Jeremiah Harnett, Dominique Pons
  • 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them
    Patent number: 6762176
    Abstract: The invention concerns novel 2-aminopyridine derivatives having an activity inhibiting NO-synthase enzymes producing nitrogen monoxide NO and/or trapping reactive forms of oxygen, the methods for preparing them, pharmaceutical compositions containing them and their therapeutic uses, particularly their use as NO-synthase inhibitors and for trapping reactive forms of oxygen whether selectively or not.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: July 13, 2004
    Assignee: Societe de Consells de Recherches et D'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Pierre-Etienne Chabrier de Lassauniere, Serge Auvin, Jerry Harnett, Dominique Pons, Gérard Ulibarri, Dennis Bigg
  • Derivatives of 2-aminopyridines, their use as medicaments and pharmaceutical compositions containing them
    Patent number: 6727239
    Abstract: A compound of the formula wherein the substituents are defined as in the specification and their pharmaceutically acceptable salts having NOS and ROS activity.
    Type: Grant
    Filed: April 2, 2003
    Date of Patent: April 27, 2004
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Pierre-Etienne Chabrier de Lassauniere, Serge Auvin, Jerry Harnett, Dominique Pons, Gérard Ulibarri, Dennis Bigg
  • Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
    Patent number: 6653312
    Abstract: Amidine compounds of the formula wherein the substituents are defined as in the application useful as NO-synthase enzyme inhibitors.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: November 25, 2003
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Serge Auvin, Pierre-Etienne Chabrier de Lassauniere, Jeremiah Harnett, Dominique Pons, Gérard Ulibarri
  • Oxidation of epoxy alcohols into carboxilic epoxy acids
    Patent number: 5084582
    Abstract: The invention relates to a method of oxidizing epoxyalcohols, in a medium containing an organic solvent and water, by means of a solid oxidizing compound, in the presence of a catalyst based on a ruthenium salt. The proportion of water relative to that of organic solvent is sufficiently small for at least the major part of the oxidizing compound to remain in the solid state in the reaction medium, which is heterogeneous.
    Type: Grant
    Filed: January 18, 1991
    Date of Patent: January 28, 1992
    Assignee: Societe Nationale Elf Aquitaine
    Inventors: Jean-Pierre Genet, Dominique Pons, Sylvain Juge